The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well. While Mounjaro had already been used by some patients "off-label" for weight lo...
FDA Approves New Weight-Loss PillWASHINGTON - The Food and Drug Administration on Tuesday approveda new weight loss drug that...Perrone, Matthew
U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug Administration said Thursday that it is approved f...
all of the destroyed fat cells are gone and will not be replaced – making the fat loss permanent. Due to its incredible success and safety record, the FDA has approved SculpSure™ as a treatment for permanent fat cell reduction.
The Food and Drug Administration (FDA) has approved a novel first-in-class drug to treat type 2 diabetes. The drug is called tirzepatide. A person has it as a once-weekly injection under the skin. It has a dual effect, lowering blood sugar and supporting weight loss better than currentl...
(Blair2023a). The first long-acting G-CSF product, eflapegrastim-xnst, was approved by the FDA last in 2022 (Kayki-Mutlu et al.2023). In 2023,efbemalenograstim alfa-vuxwhas been approved to reduce the incidence of infections with febrile neutropenia in adult patients with non-myeloid ...
The use of Liraglutide for weight loss has been recently approved by the FDA and European Medicines Agency, demonstrating clinical benefit.
Zepbound™ (tirzepatide) injection is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with obesity (BMI ≥ 30 kg/m2), or overweight (BMI ≥ 27 kg/m2) with at least one weight-related comorbid condi...
The treatment of NAFLD is problematic due to the lack of drugs accepted by the FDA in Europe. Although the guidelines recommend a narrow range of measures including lifestyle and diet changes, the use of hepatoprotective therapy is limited in NASH. The problem with this is that patients react...
Consider the headline from STAT, “FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban.” True. Now the subhead, “The scrubbing could affect the ways researchers and companies test drugs and medical devices.” Key word, “could.” The great journal...